持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/10/17 | 3,490 | 3,490 | 3,440 | 3,440 | -60 | -1.7% | 28,400 |
| 2022/10/14 | 3,460 | 3,520 | 3,435 | 3,500 | +100 | +2.9% | 43,800 |
| 2022/10/13 | 3,410 | 3,415 | 3,385 | 3,400 | -10 | -0.3% | 29,600 |
| 2022/10/12 | 3,390 | 3,425 | 3,380 | 3,410 | +20 | +0.6% | 30,500 |
| 2022/10/11 | 3,420 | 3,460 | 3,380 | 3,390 | -75 | -2.2% | 38,700 |
| 2022/10/07 | 3,425 | 3,485 | 3,410 | 3,465 | -5 | -0.1% | 38,100 |
| 2022/10/06 | 3,490 | 3,530 | 3,470 | 3,470 | -20 | -0.6% | 55,400 |
| 2022/10/05 | 3,500 | 3,525 | 3,480 | 3,490 | -5 | -0.1% | 41,600 |
| 2022/10/04 | 3,435 | 3,515 | 3,435 | 3,495 | +130 | +3.9% | 59,400 |
| 2022/10/03 | 3,335 | 3,380 | 3,310 | 3,365 | -10 | -0.3% | 51,700 |
| 2022/09/30 | 3,375 | 3,415 | 3,350 | 3,375 | -5 | -0.1% | 40,500 |
| 2022/09/29 | 3,300 | 3,400 | 3,285 | 3,380 | +110 | +3.4% | 54,400 |
| 2022/09/28 | 3,225 | 3,280 | 3,215 | 3,270 | +10 | +0.3% | 45,700 |
| 2022/09/27 | 3,275 | 3,320 | 3,260 | 3,260 | -30 | -0.9% | 41,600 |
| 2022/09/26 | 3,355 | 3,360 | 3,280 | 3,290 | -60 | -1.8% | 45,900 |
| 2022/09/22 | 3,335 | 3,375 | 3,325 | 3,350 | -10 | -0.3% | 32,700 |
| 2022/09/21 | 3,325 | 3,375 | 3,325 | 3,360 | -35 | -1% | 33,100 |
| 2022/09/20 | 3,380 | 3,405 | 3,365 | 3,395 | +25 | +0.7% | 33,200 |
| 2022/09/16 | 3,345 | 3,395 | 3,345 | 3,370 | +25 | +0.7% | 36,800 |
| 2022/09/15 | 3,365 | 3,370 | 3,340 | 3,345 | -15 | -0.4% | 28,400 |
| 2022/09/14 | 3,330 | 3,375 | 3,330 | 3,360 | -80 | -2.3% | 31,900 |
| 2022/09/13 | 3,450 | 3,460 | 3,435 | 3,440 | -5 | -0.1% | 17,500 |
| 2022/09/12 | 3,455 | 3,460 | 3,420 | 3,445 | +20 | +0.6% | 24,000 |
| 2022/09/09 | 3,400 | 3,450 | 3,400 | 3,425 | +30 | +0.9% | 49,400 |
| 2022/09/08 | 3,330 | 3,410 | 3,330 | 3,395 | +115 | +3.5% | 63,100 |
| 2022/09/07 | 3,310 | 3,330 | 3,265 | 3,280 | -30 | -0.9% | 37,700 |
| 2022/09/06 | 3,390 | 3,410 | 3,310 | 3,310 | -65 | -1.9% | 29,300 |
| 2022/09/05 | 3,355 | 3,375 | 3,310 | 3,375 | +15 | +0.4% | 35,700 |
| 2022/09/02 | 3,410 | 3,410 | 3,345 | 3,360 | -20 | -0.6% | 34,000 |
| 2022/09/01 | 3,400 | 3,400 | 3,345 | 3,380 | -55 | -1.6% | 50,000 |
| 2022/08/31 | 3,370 | 3,450 | 3,370 | 3,435 | +20 | +0.6% | 92,000 |
| 2022/08/30 | 3,370 | 3,420 | 3,370 | 3,415 | +45 | +1.3% | 35,000 |
| 2022/08/29 | 3,330 | 3,380 | 3,330 | 3,370 | -40 | -1.2% | 44,300 |
| 2022/08/26 | 3,440 | 3,445 | 3,410 | 3,410 | -15 | -0.4% | 26,900 |
| 2022/08/25 | 3,410 | 3,455 | 3,405 | 3,425 | +15 | +0.4% | 30,800 |
| 2022/08/24 | 3,410 | 3,415 | 3,375 | 3,410 | -10 | -0.3% | 40,600 |
| 2022/08/23 | 3,415 | 3,435 | 3,385 | 3,420 | -25 | -0.7% | 36,500 |
| 2022/08/22 | 3,380 | 3,455 | 3,345 | 3,445 | +40 | +1.2% | 38,200 |
| 2022/08/19 | 3,450 | 3,450 | 3,380 | 3,405 | -5 | -0.1% | 29,400 |
| 2022/08/18 | 3,475 | 3,475 | 3,395 | 3,410 | -75 | -2.2% | 36,000 |
| 2022/08/17 | 3,445 | 3,500 | 3,445 | 3,485 | +90 | +2.7% | 64,700 |
| 2022/08/16 | 3,455 | 3,455 | 3,385 | 3,395 | -60 | -1.7% | 24,300 |
| 2022/08/15 | 3,445 | 3,460 | 3,415 | 3,455 | +25 | +0.7% | 26,000 |
| 2022/08/12 | 3,395 | 3,450 | 3,370 | 3,430 | +40 | +1.2% | 43,300 |
| 2022/08/10 | 3,360 | 3,405 | 3,350 | 3,390 | +30 | +0.9% | 25,100 |
| 2022/08/09 | 3,405 | 3,430 | 3,360 | 3,360 | -45 | -1.3% | 25,600 |
| 2022/08/08 | 3,420 | 3,425 | 3,365 | 3,405 | -20 | -0.6% | 29,300 |
| 2022/08/05 | 3,370 | 3,425 | 3,370 | 3,425 | +35 | +1% | 40,400 |
| 2022/08/04 | 3,405 | 3,430 | 3,365 | 3,390 | -15 | -0.4% | 41,400 |
| 2022/08/03 | 3,475 | 3,515 | 3,385 | 3,405 | -55 | -1.6% | 73,000 |
701～
750
件表示中 / 3769件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 317,000円 | +5.1% | -7.0% | 2.52% | 20.81倍 | 0.86倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 東和薬品 | 313,000円 | +7.9% | -3.3% | 2.56% | 8.71倍 | 0.90倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ジーエヌアイ | 267,700円 | +21.7% | +999.9% | 0.00% | 12.33倍 | 4.22倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| ゼリア新薬 | 203,900円 | +3.1% | -6.5% | 2.35% | 9.46倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 153,300円 | -2.4% | -52.3% | 3.72% | 18.34倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
